archiveAstraZeneca

We should be asking much deeper questions now than simply about whether and when another stock market bubble burst might...

RayzeBio , the radiopharmaceutical therapeutics company, rose 101% to $61.40 after reaching an agreement to be acquired by Bristol Myers...

Investors trying to bounce back from a terrible year for stocks should consider Europe. They could be rewarded with an...